Literature DB >> 15200234

Mouse Huntington's disease homolog mRNA levels: variation and allele effects.

Karen T Dixon1, Jamie A Cearley, Jesse M Hunter, Peter J Detloff.   

Abstract

Huntington's disease homolog (Hdh) mRNA levels in mice with different Hdh alleles were measured. Brain Hdh mRNA levels varied up to threefold in genetically identical wild-type mice, indicating nongenetic factors influence Hdh expression. Striatal Hdh mRNA levels from an allele with a repeat expanded to 150 CAGs were diminished compared with wild-type and showed variation that might contribute to phenotypic variability in the Hdh(CAG)150 knock-in mouse model. To determine whether Hdh mRNA levels are tightly regulated, we assessed these levels in mice heterozygous for a deletion of the Hdh promoter. The loss of one allele reduced Hdh mRNA levels in most tissues, suggesting mechanisms to maintain Hdh mRNA levels are not in effect and should not impede therapies designed to destroy mutant huntingtin mRNA. Finally, we found a correlation between tissue mRNA levels and the susceptibility of the Hdh locus to Cre-mediated deletion. The two tissues with the highest levels of Hdh mRNA, testes and brain, were the only tissues susceptible to Cre-mediated recombination between loxP sites at Hdh locus. In contrast, the same Cre-expressing line caused recombination in every tissue for loxP sites at another genomic location. The pattern of Cre susceptibility at Hdh suggests a correlation between chromatin accessibility and high levels of Hdh expression in testes and brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200234      PMCID: PMC5991148          DOI: 10.3727/000000003783992234

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  51 in total

1.  Use of site-specific recombination as a probe of nucleoprotein complex formation in chromatin.

Authors:  M Schwikardi; P Dröge
Journal:  Eur J Biochem       Date:  2001-12

2.  Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference.

Authors:  Natasha J Caplen; J Paul Taylor; Victoria S Statham; Fumiaki Tanaka; Andrew Fire; Richard A Morgan
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

3.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

4.  Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease.

Authors:  N Georgiou; J L Bradshaw; E Chiu; A Tudor; L O'Gorman; J G Phillips
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

5.  Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene.

Authors:  Y H Wang; S Amirhaeri; S Kang; R D Wells; J D Griffith
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

6.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

7.  Differential expression of normal and mutant Huntington's disease gene alleles.

Authors:  F Persichetti; L Carlee; P W Faber; S M McNeil; C M Ambrose; J Srinidhi; M Anderson; G T Barnes; J F Gusella; M E MacDonald
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

8.  Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat.

Authors:  Christine M Ambrose; Mabel P Duyao; Glenn Barnes; Gillian P Bates; Carol S Lin; Jayalakshmi Srinidhi; Sarah Baxendale; Holger Hummerich; Hans Lehrach; Michael Altherr; John Wasmuth; Alan Buckler; Deanna Church; David Housman; Mary Berks; Gos Micklem; Richard Durbin; Alan Dodge; Andrew Read; James Gusella; Marcy E MacDonald
Journal:  Somat Cell Mol Genet       Date:  1994-01

9.  Effects of striatal excitotoxicity on huntingtin-like immunoreactivity.

Authors:  S B Tatter; W R Galpern; A T Hoogeveen; O Isacson
Journal:  Neuroreport       Date:  1995-05-30       Impact factor: 1.837

10.  Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade.

Authors:  L Carlock; P D Walker; Y Shan; K Gutridge
Journal:  Neuroreport       Date:  1995-05-30       Impact factor: 1.837

View more
  12 in total

1.  Early autophagic response in a novel knock-in model of Huntington disease.

Authors:  Mary Y Heng; Duy K Duong; Roger L Albin; Sara J Tallaksen-Greene; Jesse M Hunter; Mathieu J Lesort; Alex Osmand; Henry L Paulson; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2010-07-08       Impact factor: 6.150

2.  Allele-specific conditional destabilization of glutamine repeat mRNAs.

Authors:  Andrew B Crouse; Peter J Detloff
Journal:  Gene Expr       Date:  2005

3.  Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.

Authors:  Sybille Krauss; Nadine Griesche; Ewa Jastrzebska; Changwei Chen; Désiree Rutschow; Clemens Achmüller; Stephanie Dorn; Sylvia M Boesch; Maciej Lalowski; Erich Wanker; Rainer Schneider; Susann Schweiger
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.

Authors:  Ashish Kumar; Jennifer Zhang; Sara Tallaksen-Greene; Michael R Crowley; David K Crossman; A Jennifer Morton; Thomas Van Groen; Inga Kadish; Roger L Albin; Mathieu Lesort; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2016-02-14       Impact factor: 6.150

5.  Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1.

Authors:  Leroy Hubert; Yunfu Lin; Vincent Dion; John H Wilson
Journal:  Hum Mol Genet       Date:  2011-09-15       Impact factor: 6.150

6.  Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.

Authors:  Jing Jin; Qi Peng; Zhipeng Hou; Mali Jiang; Xin Wang; Abraham J Langseth; Michael Tao; Peter B Barker; Susumu Mori; Dwight E Bergles; Christopher A Ross; Peter J Detloff; Jiangyang Zhang; Wenzhen Duan
Journal:  Hum Mol Genet       Date:  2015-01-21       Impact factor: 6.150

7.  Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair.

Authors:  Yunfu Lin; John H Wilson
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

8.  Unusual structures are present in DNA fragments containing super-long Huntingtin CAG repeats.

Authors:  Daniel Duzdevich; Jinliang Li; Jhoon Whang; Hirohide Takahashi; Kunio Takeyasu; David T F Dryden; A Jennifer Morton; J Michael Edwardson
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

9.  Linking SNPs to CAG repeat length in Huntington's disease patients.

Authors:  Wanzhao Liu; Lori A Kennington; H Diana Rosas; Steven Hersch; Jang-Ho Cha; Phillip D Zamore; Neil Aronin
Journal:  Nat Methods       Date:  2008-10-19       Impact factor: 28.547

Review 10.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.